Immediate Impact
1 by Nobel laureates 75 standout
Citing Papers
Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer: 5-year outcomes of the HYPO-RT-PC randomised, non-inferiority, phase 3 trial
2019 Standout
Durable Clinical Benefit With Nivolumab Plus Ipilimumab in DNA Mismatch Repair–Deficient/Microsatellite Instability–High Metastatic Colorectal Cancer
2018 Standout
Works of S. Kaasa being referenced
The European Organisation for Research and Treatment of Cancer (EORTC) modular approach to quality of life assessment in oncology: an update.
1996
The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in Oncology
1993 Standout
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| S. Kaasa | 1034 | 1694 | 2142 | 7152 | 3545 | 15 | 11.9k | |
| K.C.A. Sneeuw | 1244 | 1961 | 2322 | 7702 | 3939 | 17 | 13.4k | |
| N.K. Aaronson | 1080 | 1807 | 2197 | 7353 | 4282 | 23 | 13.0k | |
| A. Filiberti | 986 | 1760 | 2201 | 7448 | 3599 | 26 | 12.2k | |
| M. Klee | 1092 | 1870 | 2385 | 8275 | 3783 | 23 | 13.5k | |
| Stewart B. Fleishman | 1161 | 2159 | 2742 | 8788 | 4442 | 40 | 14.5k | |
| Fumikazu Takeda | 967 | 1785 | 2241 | 7332 | 3651 | 52 | 12.2k | |
| N. Duez | 929 | 1653 | 2111 | 8512 | 4448 | 49 | 14.0k | |
| A. Cull | 2533 | 2875 | 3229 | 10271 | 4821 | 50 | 17.8k | |
| Bengt Bergman | 1090 | 2018 | 2469 | 9322 | 5467 | 98 | 15.6k | |
| S Schraub | 1250 | 1813 | 2233 | 8529 | 4756 | 106 | 15.9k |
All Works
Loading papers...